Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Second U.S. Independent Laboratory Confirms That Oculus Innovative Sciences' Microcyn(R) Technology Effective At Inactivating H1N1 Swine Flu
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of Microcyn® Technology at inactivating the H1NI Swine Influenza A. In a virucidal time-kill suspension test conducted by an independent laboratory, BioScience Laboratories, Inc., the specific Microcyn Technology formulation reduced infectivity of the swine flu virus by 4.00log10 (99.99%) reduction after just 30-seconds exposure. BioScience Laboratories, working in cooperation with the U.S. Department of Agriculture, received formal approval to acquire, house and evaluate the specific swine influenza virus in April 2009.

CPhA Applauds Efforts To Help Seniors Afford Prescription Medications
Congressional leaders and leading pharmaceutical companies have come up with a plan to reduce medication costs for millions of senior citizens enrolled in the Medicare Part D Prescription Drug program. In combination with other discount programs and rebates, the savings to the U.S. government could represent $80 billion. The Pharmaceutical Research and Manufacturers of America (PhRMA) is leading the charge to specifically close the coverage gap for patients whose medications costs fall into the "doughnut hole."
News of the day
Patient Notes - Clarity For Insurers And Doctors
Doctors will have greater clarity around releasing a patient"s full medical notes to insurance companies after the Privacy Commissioner concluded that the law allows insurers to collect only the information that they need to make insurance decisions.
Mental Health

Specialized Solutions For Brain Mapping And Soft Tissue Imaging

Carl Zeiss has developed a unique series of solutions addressing the different methods for brain mapping and soft tissue imaging. "Scientists are right now attacking one of the last secrets of mankind: imaging and reconstruction of the brain," Dr. Dirk Stenkamp, Member of the Board at Carl Zeiss SMT explains. "We specifically enable the acquisition and analysis of cell images at ultra-high resolution. For that purpose we have developed an extensive range of solutions, based on the sophisticated use of advanced electron and ion-beam microscopes," Stenkamp adds. At center stage, with a combination of a special detector system and large framestore, the SIGMA™ FE-SEM is enabling extremely fast imaging of huge areas of thin sections. "With this system, which is currently being evaluated by several leading research institutes worldwide, throughput is increased by a factor of 100," application product specialist Dr. Stewart Bean from Carl Zeiss SMT÷“s Cambridge facilities says. Extremely thin sections can be investigated by simultaneous milling and imaging using ZEISS CrossBeam® workstations like the NVision 40 or the new AURIGA. This leading-edge FIB/SEM instrument provides high resolution and now also features the possibility of investigating nonconductive samples using a unique local charge compensation method. NVision CrossBeam systems are already successfully in the field for soft tissue analysis at various institutes, including EPFL in Lausanne (Switzerland) and many others. The ORION® Helium-ion microscope offers totally new imaging possibilities. "Biological samples especially profit from the unprecedented depth of focus and the high contrast, that are inherent characteristics of imaging with helium ions," Mohan Ananth, Product Manager and application specialist at the US headquarters of Carl Zeiss SMT points out. Whenever resolution below one nanometer is required, the LIBRA® 120 PLUS energy filtering TEM from Carl Zeiss SMT provides the highest contrast imaging of soft tissue. LIBRA 120 PLUS especially matches the extreme demands in revealing structural and 3-D information of beam sensitive or frozen hydrated specimens at the nano scale. With the LIBRA 200 FEG energy filtering TEM, resolution in the Angstrē¶m and even sub-Angstrē¶m range can be provided. "We are in dialogue with researchers all over the world in order to meet their demanding requirements - now and in the future and as a part of our company mission. We are proud to be making a contribution to research work that will change our world," Stenkamp explains. Carl Zeiss SMT


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009